Understanding your triglyceride levels

No authors listed

No authors listed. Johns Hopkins Med Lett Health After 50. 1999 Nov.

. 1999 Nov;11(9):3.

No abstract available

Similar articles

Relevance of the reduction of triglycerides in the prevention of coronary heart disease.
Kesäniemi YA. Kesäniemi YA. Curr Opin Lipidol. 1998 Dec;9(6):571-4. doi: 10.1097/00041433-199812000-00009. Curr Opin Lipidol. 1998. PMID: 9868593 Review.
High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
Gotto AM Jr. Gotto AM Jr. Am Heart J. 2002 Dec;144(6 Suppl):S33-42. doi: 10.1067/mhj.2002.130301. Am Heart J. 2002. PMID: 12486414 Review.
Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
Breuer HW. Breuer HW. Curr Med Res Opin. 2001;17(1):60-73. Curr Med Res Opin. 2001. PMID: 11464448 Review.
Hypertriglyceridemia--independent risk factor or risk marker?
Hanefeld M, Lüthke K. Hanefeld M, et al. Przegl Lek. 1989;46(7):588-94. Przegl Lek. 1989. PMID: 2587786 English, Polish. No abstract available.
Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease.
Eberly LE, Stamler J, Neaton JD; Multiple Risk Factor Intervention Trial Research Group. Eberly LE, et al. Arch Intern Med. 2003 May 12;163(9):1077-83. doi: 10.1001/archinte.163.9.1077. Arch Intern Med. 2003. PMID: 12742806 Clinical Trial.